Valuation: CARMAT

Market Cap 6.15M 7.09M 5.75M 5.25M 9.88M 676M 10.04M 67.46M 26.43M 339M 26.63M 26.05M 1.13B P/E 2023
-3.09x
P/E 2024 -0.95x
Enterprise Value 59.25M 68.37M 55.46M 50.61M 95.23M 6.52B 96.83M 650M 255M 3.26B 257M 251M 10.89B EV / Sales 2023
56.1x
EV / Sales 2024 13.5x
Free-Float
89.06%
Yield 2023 *
-
Yield 2024 -
Manager TitleAgeSince
Chief Executive Officer 55 2016-08-31
Director of Finance/CFO - 2018-12-11
Chief Tech/Sci/R&D Officer - 2025-03-31
Director TitleAgeSince
Chairman 71 2024-06-24
Director/Board Member 63 2021-05-06
Director/Board Member 79 2017-04-19
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%-.--% - - 7.08M
+0.65%+3.76%-7.45%+23.57% 133B
+0.23%-1.25%-17.50%-1.03% 12.57B
+0.31%+7.25%+110.18%+145.87% 10.7B
-1.85%-2.19%-43.54%-67.82% 4.72B
+0.52%+4.05%-24.37%+38.33% 2.68B
-0.94%-6.86%-24.98%-75.40% 1.73B
-0.86%+0.43%-15.04%-13.17% 1.7B
-0.33%-2.34%-33.53%-31.81% 1.67B
Average -0.12%+210.90%-7.03%+2.32% 21.05B
Weighted average by Cap. +0.65%+361.62%-2.53%+25.24%

Financials

2023 2024
Net sales 3.84M 4.43M 3.59M 3.28M 6.17M 422M 6.27M 42.12M 16.5M 211M 16.62M 16.26M 705M 7.34M 8.47M 6.88M 6.27M 11.8M 808M 12M 80.62M 31.59M 405M 31.82M 31.13M 1.35B
Net income -53.87M -62.16M -50.43M -46.01M -86.59M -5.93B -88.05M -591M -232M -2.97B -233M -228M -9.9B -51.4M -59.31M -48.11M -43.9M -82.61M -5.66B -84M -564M -221M -2.83B -223M -218M -9.45B
Net Debt 49.64M 57.28M 46.47M 42.4M 79.79M 5.46B 81.13M 545M 213M 2.73B 215M 210M 9.12B 53.1M 61.27M 49.71M 45.36M 85.35M 5.84B 86.79M 583M 228M 2.93B 230M 225M 9.76B
Logo CARMAT
Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.
Employees
-